Research and Development
Sanctus Global is a technology-driven company powered by our robust R&D and F&D departments. We pride ourselves on hiring the most talented professionals in the industry.
The R&D department is focused on improving the consistency of formulations, developing new and innovative dosage forms, reducing costs, and enhancing the overall effectiveness of our products. Logos boasts a fully equipped Analytical Development Lab, a pilot-scale plant for technology transfer, and a cutting-edge microbiological testing facility. Our facility also partners with various CROs (Clinical Research Organizations) to conduct Bioavailability/Bioequivalence (BA/BE) studies and clinical trials. At our R&D center, we don’t just work on the latest molecules; we are committed to enhancing existing ones. We focus on improving patient compliance, bioavailability, comfort, and building trust with healthcare professionals.
Highlights
Some Features of Research and Development are
Pre-formulation Research.
Laboratory and pilot-scale development, along with stability testing.
Process optimization and validation through scale-up.
Technology transfer for the introduction of new products.
Regulatory affairs dossier support and assistance.
Focusing on novel molecules and innovative dosage forms, including tablet-in-capsule technology and modified-release oral formulations.
Introduction of novel molecules, including Bempedoic Acid 180 mg tablets, Favipiravir tablets (200 mg, 400 mg, 800 mg) and their combination kits, Molnupiravir tablets, and several others.
We are preparing to launch the Fixed Dose Combination (FDC) of Bempedoic Acid and Ezetimibe tablets, as well as the combination kit of Nirmatrelvir and Ritonavir, along with several other new combinations in the diabetes and neurology therapeutic areas.
To perform stability studies on developmental batches under different conditions.
Comprehensive documentation support for the manufacturing unit.
Preparation of Technology Transfer documents and validation protocols.
Providing support to the manufacturing unit for conducting scale-up and validation batches.